Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aveanna Healthcare Holdings (AVAH) Non-Current Debt (2021 - 2026)

Aveanna Healthcare Holdings (AVAH) has disclosed Non-Current Debt for 5 consecutive years, with $1.3 billion as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non-Current Debt rose 1.12% year-over-year to $1.3 billion, compared with a TTM value of $1.3 billion through Sep 2025, up 1.12%, and an annual FY2024 reading of $1.3 billion, changed 0.37% over the prior year.
  • Non-Current Debt was $1.3 billion for Q3 2025 at Aveanna Healthcare Holdings, up from $1.3 billion in the prior quarter.
  • Across five years, Non-Current Debt topped out at $1.3 billion in Q3 2025 and bottomed at $15.0 million in Q3 2022.
  • Average Non-Current Debt over 5 years is $1.2 billion, with a median of $1.3 billion recorded in 2024.
  • The sharpest move saw Non-Current Debt crashed 98.2% in 2022, then soared 8424.97% in 2023.
  • Year by year, Non-Current Debt stood at $829.7 million in 2021, then skyrocketed by 54.41% to $1.3 billion in 2022, then dropped by 0.37% to $1.3 billion in 2023, then fell by 0.37% to $1.3 billion in 2024, then increased by 1.39% to $1.3 billion in 2025.
  • Business Quant data shows Non-Current Debt for AVAH at $1.3 billion in Q3 2025, $1.3 billion in Q2 2025, and $1.3 billion in Q1 2025.